$BDX BECTON DICKINSON & CO Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BECTON DICKINSON & CO.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in BECTON DICKINSON & CO. Insider overview, share value development, latest insider transactions and email notifications about new events in BECTON DICKINSON & CO for free.

CIK Number: 0000010795
IRS Number: 220760120
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: BDX
Company Address: ONE BECTON DR FRANKLIN LAKE 07417

Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Market Capitalization: $37.88B
Prev close: $178.81
Average Daily Volume: 1,136,900
Days Low: $177.43
Year Low: $134.21
Year High: $181.76

BECTON DICKINSON & CO Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Borzi James WEVP & Chief Supply Chain Offcr3,707662,849shares bought: 2,543 / shares sold: -1,121 STRONG BUYNov 28 20173 months ago
BURZIK CATHERINE MDirector7,2591,297,982shares bought: 2,122 / shares sold: -1,368 BUYJan 25 201826 days ago
Conroy AlexandreExecutive Vice President28,9335,173,510shares bought: 33,964 / shares sold: -33,139 BUYNov 28 20173 months ago
ECKERT R ANDREWDirector2,867512,648shares bought: 2,479 / shares sold: 0 STRONG BUYJan 25 201826 days ago
FORLENZA VINCENT AChairman, CEO and President208,88337,350,369shares bought: 164,013 / shares sold: -125,921 BUYDec 28 20172 months ago
Fraser-Liggett ClaireDirector21,6393,869,270shares bought: 2,122 / shares sold: 0 STRONG BUYJan 25 201826 days ago
Gallagher John EVP, Corp Finance and Treasurer4,144740,989shares bought: 8,032 / shares sold: -7,645 BUYNov 27 20173 months ago
Goette RolandEVP and President, EMEA5,9611,065,886shares bought: 1,537 / shares sold: -889 STRONG BUYNov 28 20173 months ago
Groetelaars John PEVP42,5087,600,855Jan 04 20182 months ago
Jones Christopher Ian MontagueDirector14,5002,592,745shares bought: 2,122 / shares sold: 0 STRONG BUYFeb 13 20187 days ago
Khichi Samrat S.EVP and General Counsel31,3855,611,952Jan 04 20182 months ago
LARSEN MARSHALL ODirector19,7333,528,458shares bought: 2,122 / shares sold: 0 STRONG BUYJan 25 201826 days ago
Lim JamesExecutive Vice President17,5003,129,175shares bought: 9,451 / shares sold: -8,757 BUYNov 27 20173 months ago
Mas Ribo AlbertoEVP and Pres, Life Sciences20,1253,598,551shares bought: 7,065 / shares sold: -3,717 STRONG BUYNov 28 20173 months ago
Mecklenburg Gary ADirector25,4534,551,251shares bought: 2,122 / shares sold: 0 STRONG BUYFeb 13 20187 days ago
Melcher David FDirector2,228398,389shares bought: 941 / shares sold: 0 BUYJan 25 201826 days ago
OVERLOCK WILARD J JRDirector28,9425,175,119shares bought: 3,063 / shares sold: 0 STRONG BUYFeb 13 20187 days ago
Polen Thomas E JrExecutive Vice President12,8152,291,450shares bought: 37,906 / shares sold: -31,083 BUYNov 27 20173 months ago
Pomeroy ClaireDirector6,2371,115,238shares bought: 2,122 / shares sold: 0 STRONG BUYJan 25 201826 days ago
Reidy Christopher RCFO and EVP of Administration25,1854,503,330shares bought: 25,032 / shares sold: -14,526 STRONG BUYNov 28 20173 months ago
RIMEL REBECCA WDirector9,3011,663,112shares bought: 2,122 / shares sold: -684 STRONG BUYJan 25 201826 days ago
RING TIMOTHY MDirector295,75352,883,594shares bought: 488,089 / shares sold: -498,569 SELLFeb 13 20187 days ago
SCOTT BERTRAM LDirector26,9754,823,400shares bought: 2,122 / shares sold: 0 STRONG BUYJan 25 201826 days ago
Shabshab NabilExecutive Vice President9,0441,617,158shares bought: 29,276 / shares sold: -28,165 BUYNov 28 20173 months ago
Strahlman Ellen RSenior Vice President12,0452,153,766shares bought: 35,432 / shares sold: -36,309 SELLNov 27 20173 months ago
Tharby Linda MExecutive Vice President14,9432,671,958shares bought: 37,063 / shares sold: -32,994 BUYNov 28 20173 months ago

View all BECTON DICKINSON & CO insiders.

BECTON DICKINSON & CO Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 13 2018BDXBECTON DICKINSON & ...OVERLOCK WILARD J JRDirectorOption ExerciseA0.00100023,991
Feb 13 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorOption ExerciseA0.0037037
Feb 13 2018BDXBECTON DICKINSON & ...Mecklenburg Gary ADirectorOption ExerciseA0.0016106,931
Feb 13 2018BDXBECTON DICKINSON & ...Jones Christopher Ian MontagueDirectorOption ExerciseA0.0010006,099
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorOption ExerciseM143.0778,15511,181,6360
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorOption ExerciseM121.49101,06412,278,2650
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorOption ExerciseM110.0493,94610,337,8180
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorOption ExerciseM88.87100,3398,917,1270
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorOption ExerciseM63.66113,6447,234,5770
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorSellS217.8211,4212,487,722170,688182.1 K to 170.7 K (-6.27 %)
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorSellS217.8226,9125,861,972182,109209 K to 182.1 K (-12.88 %)
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorSellD217.8251,24311,161,750209,021260.3 K to 209 K (-19.69 %)
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorBuyM143.0778,15511,181,636260,264182.1 K to 260.3 K (+42.92 %)
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorSellS217.8244,7959,757,247182,109226.9 K to 182.1 K (-19.74 %)
Feb 12 2018BDXBECTON DICKINSON & ...RING TIMOTHY MDirectorSellD217.8256,26912,256,514226,904283.2 K to 226.9 K (-19.87 %)

View all BECTON DICKINSON & CO insider transactions.